Condition
Tuberculous Pleurisy
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT00524147Not ApplicableCompletedPrimary
Drainage of Tuberculous Pleural Effusions
NCT00338793Not ApplicableCompletedPrimary
Corticosteroids in the Treatment of Tuberculous Pleurisy
NCT00313066Unknown
Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion
Showing all 3 trials